Renate Winter

Parasitic infections of domestic cats, Felis catus, in western Hungary.

During 2011, faeces from 235 owned domestic cats from a rural area in western Hungary were examined using standard coproscopical techniques. The overall prevalence of cats with endoparasites was 39.6% (95% CI 33.3-46.1). The most frequently identified faecal forms were those of ascarids (Toxocara, 17.4%; Toxascaris 7.2%), followed by those of Aelurostrongylus lungworms (14.5%), hookworms (11.1%), taeniid cestodes (4.7%), Cystoisospora coccidians (4.3%), and capillarids (3.8%). Single and multiple infections with up to five parasites concurrently were founded in 24.7% and 14.9% of the cats, respectively. Mixed endoparasite infections were recorded more frequently (p=0.0245) in cats greater than one year old compared to younger cats. Young cats (≤ 1 year) were parasitized more frequently (p<0.05) with ascarids and Cystoisospora spp. but demonstrated infections of hookworms, lungworms and taeniid cestodes less often than the older cats. Cats with taeniid infection were more likely (p<0.05) to harbour Toxocara, hookworm, Aelurostrongylus, and capillarid infections than cats without taeniid cestodes. Cats of owners who claimed the use of wormers were less frequently helminth-positive compared to cats whose owners did not use anthelmintics (21.2% vs. 44.4%; p=0.001). A subset of 115 faecal samples screened by a coproantigen ELISA revealed Giardia-specific antigen in 37.4% samples. Giardia cysts were found by immunofluorescent staining in 30 of the 43 samples tested positive for Giardia by ELISA. In addition, ectoparasites collected from 82 cats by body search and combing were identified. Fleas (1-30 per cat), biting lice (Felicola subrostratus), and ticks (1-5 per cat) were isolated from 58, 1 and 43 cats, respectively. Ctenocephalides felis was identified on all flea infested cats while single specimens of C. canis and Pulex irritans were recovered from three and two cats, respectively. All but one tick collected were adult Ixodes ricinus; the single other tick was a nymph of I. canisuga. By providing basic data on the epidemiology of parasitic infections, the results of this survey should emphasize the need of attending to parasites of cats from the veterinary point of view with respect to both appropriate diagnostics and control.

Endoparasites of cats from the Tirana area and the first report on Aelurostrongylus abstrusus (Railliet, 1898) in Albania

ZusammenfassungIm Kot von Katzen aus dem Großraum Tirana wurden Larven nachgewiesen, die für eine Infektion mit dem Lungenwurm Aelurostrongylus abstrusus sprachen. Dieser Befund konnte durch die Sektion von 18 Katzen bestätigt werden, von denen 9 einen Befall der Lungen mit adulten A. abstrusus (Railliet, 1898) (Prävalenz 50 %; 1–11 Würmer) aufwiesen. Neben A. abstrusus wurden Eucoleus aerophilus (16,7 %; 1–9 Würmer) aus der Lunge sowie Toxocara cati (83,3 %; 2–33 Würmer), Ancylostoma tubaeforme (44,4 %; 1–20 Würmer), Dipylidium caninum (83,3 %; 1–164 Würmer), Joyeuxiella pasqualei (11,1 %; 1–3 Würmer) und ein Kratzer (Acanthozephala) aus dem Magen–Darm–Trakt der Katzen isoliert. Im Rektumkot waren Oozysten von Cystoisospora felis und C. rivolta bei 5,6 % bzw. 11,1 % der sezierten Katzen nachweisbar. Die vorläufigen Ergebnis sprechen für eine hohe Prävalenz an Endoparasiten in den freilebenden Katzen aus Tirana. Das Vorkommen von A. abstrusus, dessen Befall mit respiratorischen Symptomen einhergehen kann, wird hiermit erstmalig in Albanien beschrieben.SummaryFollowing the recovery of first–stage nematode larvae indicative of Aelurostrongylus abstrusus infection in the faeces of free-roaming cats from the greater Tirana area, examination of 18 cats at necropsy revealed nine of them harbouring adult A. abstrusus (Railliet, 1898) in the lungs (prevalence, 50%; range, 1–11). In addition to A. abstrusus, Eucoleus aerophilus (16.7%; 1–9) was isolated from the lungs, and Toxocara cati (83.3%; 2–33), Ancylostoma tubaeforme (44.4%; 1–20), Dipylidium caninum (83.3%; 1–164), Joyeuxiella pasqualei (11.1%; 1–3) and one specimen of an acanthocephalan (5.5%) were recovered from the gastrointestinal tract. Furthermore, oocysts of Cystoisospora felis and C. rivolta were found in the rectal faeces of 5.6% and 11.1% of the cats, respectively. In conclusion, the prevalence of endoparasite infection in free–roaming cats in Tirana can be considered to be high. The occurrence of A. abstrusus, which may cause respiratory distress in cats, is reported for the first time in Albania.

Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep: 1. Evaluation of weight gain, feed consumption and carcass value

To evaluate the prophylactic and therapeutic effects of an ivermectin controlled-release capsule (IVM-CRC) on the productivity of growing sheep infested with Psoroptes ovis 24 male and 24 female Merino landrace lambs, 5-6 months old and weighing 21.2-35.0 kg, were used. Sixteen replicates of three animals were formed based on sex and Day 0 body weight. Within each replicate animals were randomly allocated to one of three groups: untreated control; IVM-CRC on Day 0; IVM-CRC on Day 84. For treatment an IVM-CRC for sheep weighing 20-45 kg was used which is designed to deliver ivermectin at a minimum dose of 20 microg/kg per day for 100 days. The lambs were infested with 50-60 P. ovis mites each on Days 14 and 21. Mites in skin scrapings were counted on Days 70, 84, 98, 112 and 126. Body weight and feed consumption were measured every 2 weeks from Day 0 to 126. The animals were slaughtered on Day 127 and their carcasses evaluated. The IVM-CRC treatment on Day 0 prevented the establishment of P. ovis. All untreated lambs became infested. The lambs treated with an IVM-CRC on Day 84 became mite-free from Day 112 onwards. The lambs treated on Day 0 had significantly (p<0.05) greater body weight gain from Day 0 to 84 (13.9 kg) and Day 0 to 126 (20.9 kg) than the untreated controls (9.6 and 12.8 kg, respectively) and the sheep treated on Day 84 (8.4 and 14.9 kg, respectively). Feed consumption (Days 0-126) for sheep treated with the IVM-CRC on Day 0 was higher than for sheep treated on Day 84 (p<0.05) and for the untreated controls (p<0.1). The carcasses of sheep treated with the IVM-CRC on Day 0 had significantly (p<0.05) higher warm and cold weights, carcass yield, rib eye area and back fat thickness than the untreated control group and the sheep treated with the IVM-CRC on Day 84. The sheep treated with the ivermectin CRC on either Day 0 or 84 had significantly (p<0.05) better muscle scores and lower muscle pH 1h post-slaughter than the untreated controls. There was no significant (p>0.1) difference between warm and cold carcass weights, carcass yield and rib eye area between sheep treated on Day 84 and untreated controls.

Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. 2. Evaluation of wool production and leather value.

To evaluate the prophylactic and therapeutic effects of an ivermectin controlled-release capsule (IVM-CRC) on the productivity of growing sheep infested with Psoroptes ovis 24 male and 24 female Merino landrace lambs, 5-6 months old and weighing 21.2-35.0 kg, were used. Sixteen replicates of three animals were formed based on sex and Day 0 body weight. Within each replicate animals were randomly allocated to one of three groups: untreated control; IVM-CRC on Day 0; IVM-CRC on Day 84. For treatment an IVM-CRC for sheep weighing 20-45 kg was used which is designed to deliver ivermectin at a minimum dose of 20 microg/kg/day for 100 days. The lambs were infested with 50-60 P. ovis mites each on days 14 and 21. The animals were shorn on Day 126. After slaughter on Day 127 the quality of the leather produced from their skins was evaluated. The IVM-CRC treatment on Day 0 prevented the establishment of P. ovis. All untreated lambs became infested. The lambs treated with an IVM-CRC on Day 84 became mite-free from Day 112 onwards. The lambs which were treated on Day 0 had significantly (p<0.05) greater clean fleece weight (1.5 kg) and fleece yield (52.1%) than the untreated controls (0.9 kg and 34.1%, respectively) or than lambs treated on Day 84 (1.0 kg and 47.8%, respectively). Clean fleece weight and fleece yield were in the tendency (p=0.055) or significantly (p<0. 001) greater, respectively, for lambs treated on Day 84 than for the untreated controls. The chrome tanned dried crust leather of all untreated controls and six of the 16 lambs treated on Day 84 showed grain surface defects such as discolourations, indurations and coarse, pitted grain. The useful (defect-free) leather size was significantly (p<0.01) higher for the lambs treated on Day 0 (100%) than for the lambs treated on Day 84 (82.7%) and the untreated controls (7.8%). The physical testing revealed that the leather of sheep treated on Day 0 had significantly (p<0.05) higher thickness, elongation break and tear resistance than the leather of both untreated controls and sheep treated on Day 84. There were no significant differences in the physical characteristics of the leather of the untreated controls and the sheep treated on Day 84.

Efficacy of a novel topical fipronil, (S)-methoprene, eprinomectin and praziquantel combination against naturally acquired intestinal nematode and cestode infections in cats.

The efficacy of a novel topical combination formulation of fipronil, (S)-methoprene, eprinomectin and praziquantel against naturally acquired intestinal nematode and cestode infections in cats was evaluated in seven negative control, blinded studies. Cats were selected based on a pre-treatment faecal examination indicating a patent infection with at least hookworms (two studies), Toxocara ascarids (one study), taeniid cestodes (two studies) or Dipylidium cestodes (two studies). In each study, cats were assigned randomly to blocks of two animals each, based on decreasing pre-treatment body weight and were randomly allocated to one of two groups of six to 12 cats: untreated (control) or treated with topical fipronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin (0.4%, w/v) and praziquantel (8.3%, w/v) (BROADLINE(®), Merial) at 0.12 mL/kg body weight (providing a minimum of 10mg fipronil+12 mg S-methoprene+0.5mg eprinomectin+10mg praziquantel per kg body weight). The topical treatment was administered directly on the skin in the midline of the neck in a single spot once on Day 0. For parasite recovery and count, cats were euthanized humanely and necropsied seven or ten days after treatment. A single treatment with the novel topical combination product provided 91% efficacy against Ancylostoma braziliense, ≥ 99% efficacy against Ancylostoma tubaeforme, and >97% efficacy against Toxocara cati. Similarly, excellent efficacy was established against Taenia taeniaeformis, Dipylidium caninum and Diplopylidium spp. as demonstrated by >97% and up to 100% reductions of cestode counts in the treated cats when compared to the untreated controls (P<0.01). All cats accepted the treatment well based on health observations post-treatment and daily health observations. No adverse experiences or other health problems were observed throughout the studies. The results of this series of controlled studies demonstrated high efficacy and excellent acceptability of the novel topical combination formulation of fipronil, (S)-methoprene, eprinomectin and praziquantel against a broad range of feline intestinal nematode and cestode infections.

Efficacy of an ivermectin controlled-release capsule against some rarer nematode parasites of sheep.

A controlled trial was conducted to evaluate the efficacy of the intraruminal ivermectin controlled-release capsule (CRC) (IVOMEC Maximizer CR Capsule for Sheep, Merial Ltd.) against induced incoming third-stage larvae and established adult infections with some rarer gastrointestinal nematode parasites of sheep. Twenty-one worm-free lambs were allocated by restricted randomisation based on body weight within sex to one of the following treatments: unmedicated control, ivermectin CRC given on Day 0 prior to induced infection, and ivermectin CRC given on Day 70 after establishment of induced infection. The ivermectin CRC delivers ivermectin at a minimum dose rate of 20 microg/kg/day for 100 days. Infections were induced by daily administration of third-stage larvae for five consecutive days. Nematodes were counted on Day 84, 14 days after treatment of established infection. The treatment with the ivermectin CRC prevented the establishment of Ostertagia leptospicularis, O. ostertagi, Bunostomum trigonocephalum, Cooperia oncophora, C. punctata, C. surnabada, Nematodirus helvetianus, N. roscidus and Strongyloides papillosus by >99% as compared with the untreated controls (p < 0.01). The administration of the ivermectin CRC reduced established adult infections of O. ostertagi, B. trigonocephalum, C. oncophora, C. punctata, C. surnabada, N. roscidus and S. papillosus by >99% (p < 0.01), and reduced established adult infections of O. leptospicularis and N. helvetianus by 96.5 and 98.4% (p < 0.01), respectively.